DK158263C - Decahydroquinolinolderivater eller farmaceutisk acceptable syreadditionssalte deraf samt farmaceutiske eller veterinaere midler indeholdende disse - Google Patents

Decahydroquinolinolderivater eller farmaceutisk acceptable syreadditionssalte deraf samt farmaceutiske eller veterinaere midler indeholdende disse

Info

Publication number: DK158263C
Authority: DK; Denmark
Prior art keywords: pharmaceutical; acid addition; addition salts; acceptable acid; agents containing
Prior art date: 1984-06-13

Application number

DK264385A

Other languages

English (en)

Other versions

DK264385D0 (da

DK264385A (da

DK158263B (da

Inventor

Maurice Prost

Michel De Claviere

Peter Polster

Original Assignee

Sanofi Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1984-06-13

Filing date

1985-06-12

Publication date

1990-10-08

1985-06-12 Application filed by Sanofi Sa filed Critical Sanofi Sa

1985-06-12 Publication of DK264385D0 publication Critical patent/DK264385D0/da

1985-12-14 Publication of DK264385A publication Critical patent/DK264385A/da

1990-04-23 Publication of DK158263B publication Critical patent/DK158263B/da

1990-10-08 Application granted granted Critical

1990-10-08 Publication of DK158263C publication Critical patent/DK158263C/da

Links

239000002253 acid Substances 0.000 title abstract 2
239000003795 chemical substances by application Substances 0.000 title 1
-1 2,3-methylenedioxy Chemical group 0.000 abstract 2
125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 abstract 2
206010002383 Angina Pectoris Diseases 0.000 abstract 1
WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 abstract 1
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract 1
ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical group [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 abstract 1
NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
239000005864 Sulphur Chemical group 0.000 abstract 1
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical group BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 abstract 1
229910052794 bromium Inorganic materials 0.000 abstract 1
239000011575 calcium Substances 0.000 abstract 1
229910052791 calcium Inorganic materials 0.000 abstract 1
125000004432 carbon atom Chemical group C* 0.000 abstract 1
210000000748 cardiovascular system Anatomy 0.000 abstract 1
210000000170 cell membrane Anatomy 0.000 abstract 1
239000000460 chlorine Chemical group 0.000 abstract 1
229910052801 chlorine Inorganic materials 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
229910052731 fluorine Inorganic materials 0.000 abstract 1
239000011737 fluorine Substances 0.000 abstract 1
125000001153 fluoro group Chemical group F* 0.000 abstract 1
239000001257 hydrogen Substances 0.000 abstract 1
229910052739 hydrogen Inorganic materials 0.000 abstract 1
125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
239000003112 inhibitor Substances 0.000 abstract 1
239000001301 oxygen Substances 0.000 abstract 1
229910052760 oxygen Inorganic materials 0.000 abstract 1
230000001575 pathological effect Effects 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
208000011580 syndromic disease Diseases 0.000 abstract 1
230000005945 translocation Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/233—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 4
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Diabetes (AREA)
Hematology (AREA)
Obesity (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Other In-Based Heterocyclic Compounds (AREA)
Quinoline Compounds (AREA)

DK264385A 1984-06-13 1985-06-12 Decahydroquinolinolderivater eller farmaceutisk acceptable syreadditionssalte deraf samt farmaceutiske eller veterinaere midler indeholdende disse DK158263C (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR8409242A FR2565979B1 (fr)	1984-06-13	1984-06-13	Nouveaux derives de decahydroquinoleinol, leur procede de preparation et les compositions les contenant
FR8409242		1984-06-13

Publications (4)

Publication Number	Publication Date
DK264385D0 DK264385D0 (da)	1985-06-12
DK264385A DK264385A (da)	1985-12-14
DK158263B DK158263B (da)	1990-04-23
DK158263C true DK158263C (da)	1990-10-08

Family

ID=9304961

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK264385A DK158263C (da)	1984-06-13	1985-06-12	Decahydroquinolinolderivater eller farmaceutisk acceptable syreadditionssalte deraf samt farmaceutiske eller veterinaere midler indeholdende disse

Country Status (15)

Country	Link
US (1)	US4663330A (da)
EP (1)	EP0169186B1 (da)
JP (1)	JPS6110558A (da)
AT (1)	ATE33135T1 (da)
AU (1)	AU575758B2 (da)
BE (1)	BE902633A (da)
CA (1)	CA1286673C (da)
DE (1)	DE3561946D1 (da)
DK (1)	DK158263C (da)
ES (1)	ES8707725A1 (da)
FR (1)	FR2565979B1 (da)
GR (1)	GR851422B (da)
NZ (1)	NZ212387A (da)
PT (1)	PT80624B (da)
ZA (1)	ZA854260B (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR100237166B1 (ko) *	1997-03-26	2000-01-15	홍상복	이온빔을 이용한 TiN박막의 코팅방법

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BE791678A (fr) *	1971-11-23	1973-05-21	Labaz	Nouveaux derives de decahydroquinoleinol, leur procede de preparation ainsi que les compositions therapeutiques les contenant
US4173636A (en) *	1975-12-16	1979-11-06	Labaz	Decahydroquinolines, pharmaceutical compositions and methods of use
FR2465724A1 (fr) *	1979-09-19	1981-03-27	Sanofi Sa	Nouveaux derives de decahydroquinoleinol, leur procede de preparation ainsi que leurs applications en therapeutique
FR2549475B1 (fr) *	1983-07-18	1986-02-07	Labaz Sanofi Nv	Nouveaux derives de benzofuranne, leur preparation et leur utilisation therapeutique

1984
- 1984-06-13 FR FR8409242A patent/FR2565979B1/fr not_active Expired
1985
- 1985-06-05 ZA ZA854260A patent/ZA854260B/xx unknown
- 1985-06-11 BE BE0/215168A patent/BE902633A/fr not_active IP Right Cessation
- 1985-06-11 DE DE8585870083T patent/DE3561946D1/de not_active Expired
- 1985-06-11 GR GR851422A patent/GR851422B/el unknown
- 1985-06-11 PT PT80624A patent/PT80624B/pt not_active IP Right Cessation
- 1985-06-11 AT AT85870083T patent/ATE33135T1/de not_active IP Right Cessation
- 1985-06-11 EP EP85870083A patent/EP0169186B1/fr not_active Expired
- 1985-06-12 DK DK264385A patent/DK158263C/da not_active IP Right Cessation
- 1985-06-12 CA CA000483817A patent/CA1286673C/en not_active Expired - Fee Related
- 1985-06-12 AU AU43605/85A patent/AU575758B2/en not_active Ceased
- 1985-06-12 NZ NZ212387A patent/NZ212387A/en unknown
- 1985-06-13 US US06/744,213 patent/US4663330A/en not_active Expired - Fee Related
- 1985-06-13 JP JP60129095A patent/JPS6110558A/ja active Pending
- 1985-06-13 ES ES544111A patent/ES8707725A1/es not_active Expired

Also Published As

Publication number	Publication date
PT80624B (en)	1987-04-28
FR2565979B1 (fr)	1987-03-20
US4663330A (en)	1987-05-05
AU575758B2 (en)	1988-08-04
BE902633A (fr)	1985-12-11
NZ212387A (en)	1987-10-30
ES8707725A1 (es)	1986-05-16
ZA854260B (en)	1987-02-25
PT80624A (en)	1985-07-01
FR2565979A1 (fr)	1985-12-20
EP0169186B1 (fr)	1988-03-23
ES544111A0 (es)	1986-05-16
GR851422B (da)	1985-11-25
ATE33135T1 (de)	1988-04-15
DK264385D0 (da)	1985-06-12
DK264385A (da)	1985-12-14
EP0169186A1 (fr)	1986-01-22
AU4360585A (en)	1985-12-19
CA1286673C (en)	1991-07-23
JPS6110558A (ja)	1986-01-18
DK158263B (da)	1990-04-23
DE3561946D1 (en)	1988-04-28

Legal Events

Date	Code	Title	Description
1994-02-28	PBP	Patent lapsed

Publication	Publication Date	Title
DE69524103D1 (de)	2002-01-03	Fluorinierte 2-nitroimidazole analoge zur detektion von hypoxischen tumorzellen
DE3561819D1 (en)	1988-04-14	Derivatives of methylenediphosphonic acid, process for their preparation and antirheumatic pharmaceutical compositions containing them
SE8500107L (sv)	1985-07-13	Nya 8-alfa-acylaminoergoline
DK282285A (da)	1985-12-23	Hidtil ukendte 8-alkylthio-2-piperazino-pyrimido(5,4-d)pyrimidiner,deres fremstilling og laegemidler indeholdende disse forbindelser
DK158263C (da)	1990-10-08	Decahydroquinolinolderivater eller farmaceutisk acceptable syreadditionssalte deraf samt farmaceutiske eller veterinaere midler indeholdende disse
FI871637A0 (fi)	1987-04-14	Foerfarande foer framstaellning av 1,5-benzotiazepinderivat.
DK164861C (da)	1993-01-18	Hidtil ukendte benzofuranderivater, en fremgangsmaade til deres fremstilling og farmaceutiske eller veterinaere midler indeholdende et saadant derivat
DK19885D0 (da)	1985-01-16	3-alkoxy-2-(n-pyrrolidino)-n-pyridyl-n-furyl (eller thienyl)-methyl-propylaminer, fremgangsmaade til fremstilling deraf, samt farmaceutiske midler indeholdende disse
ES8401761A1 (es)	1984-01-01	Un procedimiento para la preparacion de derivados de 1-(3,4,5-trimetoxicinamoil)-4-aminocarboniletil-piperazina sustituidos.
ATE38040T1 (de)	1988-11-15	Phosphonsaeureester.
ATE29251T1 (de)	1987-09-15	Aminopyridincarbonsaeure-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ATE9892T1 (de)	1984-11-15	Dibenzocycloheptenylidene und ihre verwendung in pharmazeutischen zusammensetzungen.
DK469381A (da)	1983-04-24	Piperidinderivater og fremgangsmaade til deres fremstilling
DK30284A (da)	1984-07-25	Pyrrolidiner
IT1210914B (it)	1989-09-29	Eterociclilfenilsolfonil e fosfonilamidine sostituite, procedimento per la loro preparazione e loro uso farmaceutico.